Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

MONDAY, March 24, 2025 (HealthDay News) -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study ...

The blood test for CA-125, a commonly used marker for ovarian cancer, was never elevated for her, even when she was diagnosed with ovarian cancer at 38. "All three times that I was diagnosed with ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

One of the two most common ways to test for ovarian cancer is to check for elevated levels of a protein called CA-125 in the patient’s blood, according to the American Cancer Society.

A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...

The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood, and ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their ...